The global decrease in cancer mortality: trends and disparities
D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri, D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri
Abstract
Background: A decrease in cancer mortality has been reported in the United States, Europe, and other high-income regions during the last two decades. Whether similar trends apply to low-to-middle income countries-and globally-is unclear.
Design: The aim of this descriptive study is to compare cancer mortality in all countries with high- or intermediate-quality data on death certificates according to the World Health Organization (WHO) mortality database for the years 2000 through 2010. We included 60 countries in the analysis and calculated age-adjusted mortality rates for all cancer combined and for the commonest cancers worldwide: lung, stomach, breast, colorectal, uterine, and prostate.
Results: A decrease in overall cancer mortality rate of ∼1% per year was observed in higher and lower income regions and in both sexes. In 2010, 696 000 cancer deaths were avoided on a global scale compared with 2000 rates (426 000 in men, 271 000 in women). However, the mortality of liver cancer in both sexes and lung cancer in females increased in many countries'.
Conclusions: The individual risk of dying from cancer decreased in all countries with reliable data. This decrease was chiefly due to favorable trends in the commonest specific cancers. Liver cancer in both sexes and lung cancer in women, which show increasing mortality rates, constitute a priority for prevention and further research.
Keywords: cancer; data collection/standards; global health; mortality; registries/standards; vital statistics.
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Source: PubMed
Kommende kliniske forsøg
-
Antalya City HospitalIkke rekrutterer endnuSmertebehandling | Pericapsular nervegruppeblok (PENG-blok) | Hofteproteser, i alt | Lateral femoral kutan nerveblok | Quadro-Iliac Plan Blok
-
Medipol UniversityIkke rekrutterer endnu
-
Balikesir UniversityIkke rekrutterer endnuLipødemTyrkiet (Türkiye)
-
Aveta Biomics, Inc.Ikke rekrutterer endnuHoved- og halskræft | Mundhulekarcinom | Oropharynx Planocellulært karcinom | Mundhule | Mundhule pladecellekarcinom | Hoved og hals (HNSCC) | Oropharyngeal
-
The University of Texas Health Science Center at...Trauma Research and Combat Casualty Care Collaborative (TRC4)RekrutteringPosttraumatisk stresslidelse PTSDForenede Stater
-
Hoffmann-La RocheRekrutteringMultipel scleroseDet Forenede Kongerige, Forenede Stater, Mexico, Brasilien
-
Fred Hutchinson Cancer CenterArcus Biosciences, Inc.; Bench to Bedside (B2B)Ikke rekrutterer endnuMetastatisk nyrebækken Urothelial Carcinom | Metastatisk Ureter Urothelial Carcinoma | Stadie IV blærekræft AJCC v8 | Stadie IV nyrebækkenkræft AJCC v8 | Stadie IV Ureterkræft AJCC v8 | Uoperabelt blæreurothelial karcinom | Uoperabelt nyrebækken Urothelial Carcinom | Uoperabelt Ureter Urothelial Carcinoma og andre forholdForenede Stater
-
Intrinsic TherapeuticsIkke rekrutterer endnuDiskusprolaps | Lumbar Disc Herniation SurgeryForenede Stater
-
Imam Abdulrahman Bin Faisal UniversityIkke rekrutterer endnu
-
Gaziantep Islam Science and Technology UniversityThe Scientific and Technological Research Council of TurkeyIkke rekrutterer endnuPostpartum Family Planning CounselingTyrkiet (Türkiye)
-
Rebecca Ahrens-NicklasIkke rekrutterer endnuUrea cyklus lidelser | Carbamoyl-phosphatsyntase I mangelForenede Stater
-
National Cancer Institute (NCI)Ikke rekrutterer endnuHoved- og halskræft | Nasopharyngealt karcinom | Hypopharynx kræft | Adenoid cystisk karcinom | Prostatakræft | Planocellulært karcinom i hoved og hals | Orofarynx pladecellekarcinom | Oralt planocellulært karcinom | Spytkirtelkræft | Paranasale sinus-neoplasmer | Metastatisk kastrationsresistent prostatakræft | Carcinom i LarynxForenede Stater